Displaying drugs 5426 - 5450 of 7024 in total
Zemirciclib
Investigational
Quinacrine
An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
Investigational
Gartisertib
Investigational
2'-Deoxycytidine
Experimental
Investigational
Morin
Experimental
Aroplatin
Investigational
Netakimab
Netakimab is under investigation in clinical trial NCT03447704 (International Multicenter Comparative Randomized Placebo-controlled Clinical Study of Efficacy and Safety of BCD-085 in Patients With Ankylosing Spondylitis).
Investigational
BMS-770767
BMS-770767 is under investigation in clinical trial NCT01058083 (Safety Study of BMS-770767 in Subjects With Hypercholesterolemia).
Investigational
Ralmitaront
Ralmitaront is under investigation in clinical trial NCT04512066 (A Trial of the Efficacy and the Safety of RO6889450 (Ralmitaront) vs Placebo in Patients With an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder).
Investigational
Dersimelagon
Investigational
Imifoplatin
Investigational
Oseltamivir acid
Experimental
SOBI-003
SOBI-003 is a chemically modified variant of a recombinant human sulfamidase. It is under investigation in clinical trial NCT03811028 (A Study to Assess the Safety, Tolerability, and Efficacy of Long-term SOBI003 Treatment in Pediatric MPS IIIA Patients).
Investigational
Bos taurus colostrum immunoglobulins
Investigational
MG-4101
Investigational
Cytidine-5'-diphospho-beta-D-xylose
Experimental
Cyclohexyl-Hexyl-Beta-D-Maltoside
Experimental
2-Cyclopropylmethylenepropanal
Experimental
Cmp-2-Keto-3-Deoxy-Octulosonic Acid
Experimental
2-(2-HYDROXY-CYCLOPENTYL)-PENT-4-ENAL
Experimental
Pagibaximab
Investigational
Displaying drugs 5426 - 5450 of 7024 in total